Pricing Log in Create free account

Dermata Therapeutics, Inc. (DRMA) vs OSR Health, Inc. (OSRH)

Dermata Therapeutics, Inc. and OSR Health, Inc. are both Biotechnology companies. Dermata Therapeutics, Inc. and OSR Health, Inc. are of similar size ($4.1M and $3.8M). Dermata Therapeutics, Inc. has the higher net margin (0.00% vs −593.2%) and the higher return on invested capital (0.00% vs −8.19%). Across the 13 metrics below, Dermata Therapeutics, Inc. leads on 7 and OSR Health, Inc. on 6.

Valuation

Metric DRMA OSRH Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.73 9.40
P/B 0.89 0.04 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.07 n/m 0.66
EV/Sales n/m 4.90 9.02
Earnings yield (585.53%) (264.00%) (32.88%)
Free cash flow yield (259.42%) (154.77%) (23.13%)

Profitability

Metric DRMA OSRH Biotechnology median
Gross margin — 35.29% 68.51%
Operating margin 0.00% (933.72%) 0.00%
Net margin 0.00% (593.21%) 0.00%
Free cash flow margin 0.00% (398.26%) 0.00%
Return on equity (183.89%) (8.13%) (51.96%)
Return on assets (139.93%) (6.10%) (46.06%)
Return on invested capital 0.00% (8.19%) 0.00%

Growth

Metric DRMA OSRH Biotechnology median
Revenue growth (TTM) — (50.24%) 6.76%
EPS growth (last fiscal year) 89.84% 83.31% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRMA OSRH Biotechnology median
Debt to equity 0.00 0.04 0.00
Current ratio 2.81 0.18 4.97
Net debt to EBITDA 0.97 (0.29) 1.01

Dividend

Metric DRMA OSRH Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DRMA OSRH Biotechnology median
Market cap 3.78m 4.09m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack